J Rheum Dis.  2024 Jan;31(1):1-2. 10.4078/jrd.2023.0079.

Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery

• Ahn SS

• KMID: 2549630
• DOI: http://doi.org/10.4078/jrd.2023.0079

Reference

1. Chevet B, Cornec D, Casal Moura M, Cornec-Le Gall E, Fervenza FC, Warrington KJ, et al. 2023; Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice. Rheumatology (Oxford). 62:1787–803. DOI: 10.1093/rheumatology/keac623. PMID: 36315063.

2. Almaani S, Fussner LA, Brodsky S, Meara AS, Jayne D. 2021; ANCA-associated vasculitis: an update. J Clin Med. 10:1446. DOI: 10.3390/jcm10071446. PMID: 33916214. PMCID: PMC8037363. PMID: de4818316bc94ced944de92df0e57ef3.

3. Syed R, Rehman A, Valecha G, El-Sayegh S. 2015; Pauci-immune crescentic glomerulonephritis: an ANCA-associated vasculitis. Biomed Res Int. 2015:402826. DOI: 10.1155/2015/402826. PMID: 26688808. PMCID: PMC4673333.

4. Moiseev S, Novikov P, Jayne D, Mukhin N. 2017; End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant. 32:248–53. DOI: 10.1093/ndt/gfw046. PMID: 28186571.

5. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, et al. 2007; Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 18:2189–97. Erratum in: J Am Soc Nephrol 2007;18:3206. DOI: 10.1681/ASN.2007010066. PMID: 17596637.

6. Li ZY, Gou SJ, Chen M, Zhao MH. 2013; Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum. 42:515–21. DOI: 10.1016/j.semarthrit.2012.09.005. PMID: 23332902.

7. Lee YJ, Ahn SM, Oh JS, Kim YG, Lee CK, Yoo B, et al. 2023; Recovery and long-term renal outcome of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who are on dialysis at presentation. J Rheum Dis. 30:251–9. DOI: 10.4078/jrd.2023.0031. PMID: 37736589. PMCID: PMC10509644.

8. Felicetti M, Cazzador D, Padoan R, Pendolino AL, Faccioli C, Nardello E, et al. 2018; Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes. Clin Rheumatol. 37:1075–83. DOI: 10.1007/s10067-018-4019-0. PMID: 29460094.

9. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL. 2011; The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 90:19–27. DOI: 10.1097/MD.0b013e318205a4c6. PMID: 21200183.

10. Ahn SS, Lim H, Lee CH, Park YB, Park JS, Lee SW. 2022; Secular trends of incidence, prevalence, and healthcare economic burden in ANCA-associated vasculitis: an analysis of the 2002-2018 South Korea National Health Insurance Database. Front Med (Lausanne). 9:902423. DOI: 10.3389/fmed.2022.902423. PMID: 35872769. PMCID: PMC9300883. PMID: f5e57b14395e4a799cf4ea8f8aff677d.

11. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. 2010; Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 21:1628–36. DOI: 10.1681/ASN.2010050477. PMID: 20616173.

12. Ahn SS, Lee SW. 2023; Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines. J Rheum Dis. 30:72–87. DOI: 10.4078/jrd.2022.0002. PMID: 37483479. PMCID: PMC10324935.